Genitourinary Cancer
News
MRI-guided SBRT cuts radiation toxicity in prostate cancer
“These findings suggest that the technical advantages in precision of radiotherapy delivery afforded by MRI-guided SBRT translate to measurable...
Conference Coverage
‘Treatment holiday’ in prostate cancer with tailored dosing
“Personalizing dosing intervals using early-response biomarkers with 177Lu-PSMA has the potential to achieve similar overall treatment...
Article
Cancer Patients: Who’s at Risk for Venous Thromboembolism?
News
No benefit to adding limited radiation in advanced cancer
Median overall survival was not significantly better with radiotherapy, compared with the control group, nor was the objective response rate.
Article
Cancer Data Trends 2023
Conference Coverage
Multiprong strategy makes clinical trials less White
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority...
Conference Coverage
CBSM phone app eases anxiety, depression in cancer patients
Few patients with cancer have access to psycho-oncologic support.
News
FDA approves talazoparib for metastatic prostate cancer
The new approval is based on findings from the randomized, placebo-controlled, phase 3 TALAPRO-2 trial.
Conference Coverage
Huge underuse of germline testing for cancer patients
Information from germline genetic testing could affect a patient’s cancer care.
News
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get meds
On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags...